UPDATE : Tuesday, July 23, 2019
상단여백
Celltrion starts P1 trial of Xolair biosimilar
Celltrion said Monday that it initiated the phase 1 clinical trial of CT-P3...
by Lee Han-soo  |  2019-07-15 17:45
라인
Daewoong, Medytox differ in interpreting US trade agency’s order
Daewoong Pharmaceutical claimed that it has gained the upper hand in the U....
by Lee Han-soo  |  2019-07-15 17:44
라인
Korean pulmonary arterial hypertension patients’ survival far lower than Japanese
The three-year survival rate of Korean patients with pulmonary arterial hyp...
by Kim Yun-mi  |  2019-07-15 16:48
라인
Self-claimed Korea Otsuka employee causes stir on far-right website
A “self-proclaimed” Korea Otsuka Pharmaceutical employee is stirring up con...
by Lee Han-soo  |  2019-07-15 15:57
라인
Ministry extends data submission for cell therapy CureSkin
The drug regulator said it has granted S.Biomedics to extend the submission...
by Lee Hye-seon  |  2019-07-15 14:35
라인
Government faces uphill battle to look into Medytox over illicit drug
The Ministry of Food and Drug Safety said it would conduct a comprehensive ...
by Jeong Sae-im  |  2019-07-15 13:58
라인
China OKs Huonland's hyaluronic acid eye drop
Huonland, a joint venture between Huons and Beijing Northland, said that it...
by Lee Han-soo  |  2019-07-15 13:57
라인
Japanese pharma companies closely following 'Boycott Japan' campaign
Japan is moving to remove Korea from the white list of importers of its hi-...
by Lee Han-soo  |  2019-07-12 17:07
라인
Ministry to request investigation into Meditoxin approval process
The Ministry of Food and Drug Safety denied a suspicion that the ministry p...
by Lee Hye-seon  |  2019-07-12 16:29
라인
‘Myongji will show what Korean Mayo Clinic looks like’
“I came here to turn this hospital into a Korean version of Mayo Clinic, pr...
by Park Gi-taek  |  2019-07-12 15:30
라인
Daewoong to co-promote Lundbeck Korea's Alzheimer's disease treatment
Daewoong Pharmaceutical said that it has agreed to promote Lundbeck Korea’s...
by Lee Han-soo  |  2019-07-12 15:13
라인
Doctors question Pexa-Vec+Imfinzi combo’s effect on colon cancer
Colon cancer specialists questioned SillaJen’s allegation that the combinat...
by Jeong Sae-im, Kim Yun-mi  |  2019-07-12 15:13
라인
‘Nasal bacteria can inhibit respiratory virus infection’
Researchers at Seoul National University Hospital have found that respirato...
by Lee Han-soo  |  2019-07-12 15:11
라인
Court suspends decision on ministry’s order to revoke Invossa license
The Seoul Administrative Court on Thursday said it has temporarily suspende...
by Jeong Sae-im  |  2019-07-12 13:11
라인
Regulator OKs Merck Korea's relapsing-remitting multiple sclerosis treatment
Merck Biopharma Korea said that the Ministry of Food and Drug Safety has gr...
by Lee Han-soo  |  2019-07-11 17:39
라인
Nasaret International Hospital goes all out to attract foreign patients
Nasaret International Hospital said it aims to become a hub hospital in Asi...
by Lee Han-soo  |  2019-07-11 16:43
라인
Humira permitted for nursing, pregnant patients
The local regulator allowed nursing and pregnant patients to use autoimmune...
by Kim Yun-mi  |  2019-07-11 16:41
라인
SCM Life Science, MitoImmune Therapeutics to develop new treatment
SCM Life Science said that it has agreed with MitoImmune Therapeutics to de...
by Lee Han-soo  |  2019-07-11 16:40
라인
Prosecutors raid 2 lead managers of Kolon TissueGene’s IPO
The prosecution raided two securities firms that managed the initial public...
by Jeong Sae-im  |  2019-07-11 16:39
라인
Acute renal failure reported in ibandronate injections
The government warned that ibandronate injections for the treatment of oste...
by Lee Hye-seon  |  2019-07-11 13:34
여백
여백
여백
Back to Top